A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease

Frontiers in Microbiology

Volumn 1, Issue NOV, 2010, Pages

  Jones, Kathleen R ^a   Whitmire, Jeannette M ^a   Merrell, D Scott ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

CagA; Cell signaling; Gastric cancer; Helicobacter; Toxin; VacA

Indexed keywords

EID: 80053445147     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2010.00115     Document Type: Review

References (251)

1. Adrian, M., Cover, T. L., Dubochet, J., and Heuser, J. E. (2002). Multiple oligomeric states of the Helicobacter pylori vacuolating toxin demonstrated by cryo-electron microscopy. J. Mol. Biol. 318, 121-133.
2. Ahn, Y. O., Park, B. J., Yoo, K. Y., Kim, N. K., Heo, D. S., Lee, J. K., Ahn, H. S., Kang, D. H., Kim, H., Lee, M. S., and Park, T. S. (1991). Incidence estimation of stomach cancer among Koreans. J. Korean Med. Sci. 6, 7-14.
3. Akada, J. K., Aoki, H., Torigoe, Y., Kitagawa, T., Kurazono, H., Hoshida, H., Nishikawa, J., Terai, S., Matsuzaki, M., Hirayama, T., Nakazawa, T., Akada, R., and Nakamura, K. (2010). Helicobacter pylori CagA inhibits endocytosis of cytotoxin VacA in host cells. Dis. Model. Mech. 3, 605-617.
4. Akopyants, N. S., Clifton, S. W., Kersulyte, D., Crabtree, J. E., Youree, B. E., Reece, C. A., Bukanov, N. O., Drazek, E. S., Roe, B. A., and Berg, D. E. (1998). Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28, 37-53.
5. Allen, L. A., Schlesinger, L. S., and Kang, B. (2000). Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. 191, 115-128.
6. Allison, C. C., Kufer, T. A., Kremmer, E., Kaparakis, M., and Ferrero, R. L. (2009). Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. J. Immunol. 183, 8099-8109.
7. Amieva, M. R., and El-Omar, E. M. (2008). Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134, 306-323.
8. Amieva, M. R., Salama, N. R., Tompkins, L. S., and Falkow, S. (2002). Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell. Microbiol. 4, 677-690.
9. Amieva, M. R., Vogelmann, R., Covacci, A., Tompkins, L. S., Nelson, W. J., and Falkow, S. (2003). Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300, 1430-1434.
10. Argent, R. H., Hale, J. L., El-Omar, E. M., and Atherton, J. C. (2008a). Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J. Med. Microbiol. 57, 1062-1067.
11. Argent, R. H., Thomas, R. J., Letley, D. P., Rittig, M. G., Hardie, K. R., and Atherton, J. C. (2008b). Functional association between the Helicobacter pylori virulence factors VacA and CagA. J. Med. Microbiol. 57, 145-150.
12. Argent, R. H., Kidd, M., Owen, R. J., Thomas, R. J., Limb, M. C., and Atherton, J. C. (2004). Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127, 514-523.
13. Atherton, J. C., Cao, P., Peek, R. M. Jr., Tummuru, M. K., Blaser, M. J., and Cover, T. L. (1995). Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270, 17771-17777.
14. Atherton, J. C., Cover, T. L., Twells, R. J., Morales, M. R., Hawkey, C. J., and Blaser, M. J. (1999). Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J. Clin. Microbiol. 37, 2979-2982.
15. Azuma, T., Yamakawa, A., Yamazaki, S., Fukuta, K., Ohtani, M., Ito, Y., Dojo, M., Yamazaki, Y., and Kuriyama, M. (2002). Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J. Infect. Dis. 186, 1621-1630.
16. Azuma, T., Yamazaki, S., Yamakawa, A., Ohtani, M., Muramatsu, A., Suto, H., Ito, Y., Dojo, M., Yamazaki, Y., Kuriyama, M., Keida, Y., Higashi, H., and Hatakeyama, M. (2004). Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189, 820-827.
17. Backert, S., Tegtmeyer, N., and Selbach, M. (2010). The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 15, 163-176.
18. Bagnoli, F., Buti, L., Tompkins, L., Covacci, A., and Amieva, M. R. (2005). Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl. Acad. Sci. U.S.A. 102, 16339-16344.
19. Basso, D., Zambon, C. F., Letley, D. P., Stranges, A., Marchet, A., Rhead, J. L., Schiavon, S., Guariso, G., Ceroti, M., Nitti, D., Rugge, M., Plebani, M., and Atherton, J. C. (2008). Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135, 91-99.
20. Ben Mansour, K., Fendri, C., Zribi, M., Masmoudi, A., Labbene, M., Fillali, A., Ben Mami, N., Najjar, T., Meherzi, A., Sfar, T., and Burucoa, C. (2010). Prevalence of Helicobacter pylori vacA, cagA, iceA and oipA genotypes in Tunisian patients. Ann. Clin. Microbiol. Antimicrob. 9, 10.
21. Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., Richards, W. G., Du, J., Girard, L., Minna, J. D., Loh, M. L., Fisher, D. E., Velculescu, V. E., Vogelstein, B., Meyerson, M., Sellers, W. R., and Neel, B. G. (2004). Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64, 8816-8820.
22. Bhat, N. R., and Zhang, P. (1999). Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J. Neurochem. 72, 112-119.
23. Blaser, M. J. (1990). Epidemiology and pathophysiology of Campylobacter pylori infections. Rev. Infect. Dis. 12(Suppl. 1), S99-S106.
24. Blaser, M. J. (1998). Helicobacter pylori and gastric diseases. BMJ 316, 1507-1510.
25. Blaser, M. J., and Atherton, J. C. (2004). Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113, 321-333.
26. Blaser, M. J., Perez-Perez, G. I., Kleanthous, H., Cover, T. L., Peek, R. M., Chyou, P. H., Stemmermann, G. N., and Nomura, A. (1995). Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55, 2111-2115.
27. Bode, G., Barth, R., Song, Q., and Adler, G. (2001). Phospholipase C activity of Helicobacter pylori is not associated with the presence of the cagA gene. Eur. J. Clin. Invest. 31, 344-348.
28. Boncristiano, M., Paccani, S. R., Barone, S., Ulivieri, C., Patrussi, L., Ilver, D., Amedei, A., D'Elios, M. M., Telford, J. L., and Baldari, C. T. (2003). The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 198, 1887-1897.
29. Botham, C. M., Wandler, A. M., and Guillemin, K. (2008). A transgenic Drosophila model demonstrates that the Helicobacter pylori CagA protein functions as a eukaryotic Gab adaptor. PLoS Pathog. 4, e1000064. doi: 10.1371/journal.ppat.1000064.
30. Bourzac, K. M., Botham, C. M., and Guillemin, K. (2007). Helicobacter pylori CagA induces AGS cell elongation through a cell retraction defect that is independent of Cdc42, Rac1, and Arp2/3. Infect. Immun. 75, 1203-1213.
31. Brandt, S., Kwok, T., Hartig, R., Konig, W., and Backert, S. (2005). NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl. Acad. Sci. U.S.A. 102, 9300-9305.
32. Brandt, S., Shafikhani, S., Balachandran, P., Jin, S., Hartig, R., Konig, W., Engel, J., and Backert, S. (2007). Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacter pylori-induced host cell actin cytoskeletal rearrangements. FEMS Immunol. Med. Microbiol. 50, 190-205.
33. Bronte-Tinkew, D. M., Terebiznik, M., Franco, A., Ang, M., Ahn, D., Mimuro, H., Sasakawa, C., Ropeleski, M. J., Peek, R. M. Jr., and Jones, N. L. (2009). Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res. 69, 632-639.
34. Bustelo, X. R. (2000). Regulatory and signaling properties of the Vav family. Mol. Cell. Biol. 20, 1461-1477.
35. Censini, S., Lange, C., Xiang, Z., Crabtree, J. E., Ghiara, P., Borodovsky, M., Rappuoli, R., and Covacci, A. (1996). Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. U.S.A. 93, 14648-14653.
36. Chang, Y. J., Wu, M. S., Lin, J. T., Pestell, R. G., Blaser, M. J., and Chen, C. C. (2006). Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycle. Cell. Microbiol. 8, 1740-1752.
37. Chauhan, D., Kharbanda, S., Uchiyama, H., Urashima, M., Fragoso, R., Sen, J., Kufe, D. W., and Anderson, K. C. (1994). Identification of upstream signals regulating interleukin-6 gene expression during in vitro treatment of human B cells with pokeweed mitogen. Blood 84, 2243-2252.
38. Chowers, M. Y., Keller, N., Bar-Meir, S., and Chowers, Y. (2002). A defined human gastrin sequence stimulates the growth of Helicobacter pylori. FEMS Microbiol. Lett. 217, 231-236.
39. Chung, C., Olivares, A., Torres, E., Yilmaz, O., Cohen, H., and Perez-Perez, G. (2010). Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world. J. Clin. Microbiol. 48, 690-696.
40. Churin, Y., Al-Ghoul, L., Kepp, O., Meyer, T. F., Birchmeier, W., and Naumann, M. (2003). Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol. 161, 249-255.
41. Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z., Figura, N., and Rappuoli, R. (1993). Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. U.S.A. 90, 5791-5795.
42. Cover, T. L., and Blanke, S. R. (2005). Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 3, 320-332.
43. Cover, T. L., and Blaser, M. J. (1992). Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267, 10570-10575.
44. Cover, T. L., Hanson, P. I., and Heuser, J. E. (1997). Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J. Cell Biol. 138, 759-769.
45. Cover, T. L., Reddy, L. Y., and Blaser, M. J. (1993). Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin. Infect. Immun. 61, 1427-1431.
46. Crabtree, J. E., Taylor, J. D., Wyatt, J. I., Heatley, R. V., Shallcross, T. M., Tompkins, D. S., and Rathbone, B. J. (1991). Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338, 332-335.
47. Crabtree, J. E., Xiang, Z., Lindley, I. J., Tompkins, D. S., Rappuoli, R., and Covacci, A. (1995). Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J. Clin. Pathol. 48, 967-969.
48. Crew, K. D., and Neugut, A. I. (2006). Epidemiology of gastric cancer. World J. Gastroenterol. 12, 354-362.
49. Debellis, L., Papini, E., Caroppo, R., Montecucco, C., and Curci, S. (2001). Helicobacter pylori cytotoxin VacA increases alkaline secretion in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G1440-G1448.
50. de Bernard, M., Arico, B., Papini, E., Rizzuto, R., Grandi, G., Rappuoli, R., and Montecucco, C. (1997). Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Mol. Microbiol. 26, 665-674.
51. de Bernard, M., Burroni, D., Papini, E., Rappuoli, R., Telford, J., and Montecucco, C. (1998). Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol. Infect. Immun. 66, 6014-6016.
52. de Bernard, M., Papini, E., de Filippis, V., Gottardi, E., Telford, J., Manetti, R., Fontana, A., Rappuoli, R., and Montecucco, C. (1995). Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J. Biol. Chem. 270, 23937-23940.
53. Domanska, G., Motz, C., Meinecke, M., Harsman, A., Papatheodorou, P., Reljic, B., Dian-Lothrop, E. A., Galmiche, A., Kepp, O., Becker, L., Gunnewig, K., Wagner, R., and Rassow, J. (2010). Helicobacter pylori VacA toxin/subunit p34: targeting of an anion channel to the inner mitochondrial membrane. PLoS Pathog. 6, e1000878. doi: 10.1371/ journal.ppat.1000878.
54. Douraghi, M., Mohammadi, M., Oghalaie, A., Abdirad, A., Mohagheghi, M. A., Hosseini, M. E., Zeraati, H., Ghasemi, A., Esmaieli, M., and Mohajerani, N. (2008). dupA as a risk determinant in Helicobacter pylori infection. J. Med. Microbiol. 57, 554-562.
55. El-Etr, S. H., Mueller, A., Tompkins, L. S., Falkow, S., and Merrell, D. S. (2004). Phosphorylation-independent effects of CagA during interaction between Helicobacter pylori and T84 polarized monolayers. J. Infect. Dis. 190, 1516-1523.
56. Ernst, P. B., and Gold, B. D. (2000). The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol. 54, 615-640.
57. Faisst, S., and Meyer, S. (1992). Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20, 3-26.
58. Fischer, W., Puls, J., Buhrdorf, R., Gebert, B., Odenbreit, S., and Haas, R. (2001). Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42, 1337-1348.
59. Foo, J. H., Culvenor, J. G., Ferrero, R. L., Kwok, T., Lithgow, T., and Gabriel, K. (2010). Both p33 and p55 subunits of Helicobacter pylori VacA are targeted to mammalian mitochondria. J. Mol. Biol. 401, 792-798.
60. Franco, A. T., Israel, D. A., Washington, M. K., Krishna, U., Fox, J. G., Rogers, A. B., Neish, A. S., Collier-Hyams, L., Perez-Perez, G. I., Hatakeyama, M., Whitehead, R., Gaus, K., O'Brien, D. P., Romero-Gallo, J., and Peek, R. M. Jr. (2005). Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 102, 10646-10651.
61. Franco, A. T., Johnston, E., Krishna, U., Yamaoka, Y., Israel, D. A., Nagy, T. A., Wroblewski, L. E., Piazuelo, M. B., Correa, P., and Peek, R. M., Jr. (2008). Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 68, 379-387.
62. Fujikawa, A., Shirasaka, D., Yamamoto, S., Ota, H., Yahiro, K., Fukada, M., Shintani, T., Wada, A., Aoyama, N., Hirayama, T., Fukamachi, H., and Noda, M. (2003). Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat. Genet. 33, 375-381.
63. Gale, N. W., Kaplan, S., Lowenstein, E. J., Schlessinger, J., and Bar-Sagi, D. (1993). Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363, 88-92.
64. Galmiche, A., Rassow, J., Doye, A., Cagnol, S., Chambard, J. C., Contamin, S., de Thillot, V., Just, I., Ricci, V., Solcia, E., Van Obberghen, E., and Boquet, P. (2000). The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J. 19, 6361-6370.
65. Garner, J. A., and Cover, T. L. (1996). Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells. Infect. Immun. 64, 4197-4203.
66. Gauthier, N. C., Monzo, P., Gonzalez, T., Doye, A., Oldani, A., Gounon, P., Ricci, V., Cormont, M., and Boquet, P. (2007). Early endosomes associated with dynamic F-actin structures are required for late trafficking of H. pylori VacA toxin. J. Cell Biol. 177, 343-354.
67. Gauthier, N. C., Monzo, P., Kaddai, V., Doye, A., Ricci, V., and Boquet, P. (2005). Helicobacter pylori VacA cytotoxin: a probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes. Mol. Biol. Cell 16, 4852-4866.
68. Gebert, B., Fischer, W., Weiss, E., Hoffmann, R., and Haas, R. (2003). Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301, 1099-1102.
69. Gerhard, M., Lehn, N., Neumayer, N., Boren, T., Rad, R., Schepp, W., Miehlke, S., Classen, M., and Prinz, C. (1999). Clinical relevance of the Helicobacter pylori gene for blood-group antigenbinding adhesin. Proc. Natl. Acad. Sci. U.S.A. 96, 12778-12783.
70. Goto, Y., Ando, T., Yamamoto, K., Tamakoshi, A., El-Omar, E., Goto, H., and Hamajima, N. (2006). Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int. J. Cancer 118, 203-208.
71. Gupta, V. R., Patel, H. K., Kostolansky, S. S., Ballivian, R. A., Eichberg, J., and Blanke, S. R. (2008). Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog. 4, e1000073. doi: 10.1371/journal. ppat.1000073.
72. Gupta, V. R., Wilson, B. A., and Blanke, S. R. (2010). Sphingomyelin is important for the cellular entry and intracellular localization of Helicobacter pylori VacA. Cell. Microbiol. 12,1517-1533.
73. Gwack, J., Shin, A., Kim, C. S., Ko, K. P., Kim, Y., Jun, J. K., Bae, J., Park, S. K., Hong, Y. C., Kang, D., Chang, S. H., Shin, H. R., and Yoo, K. Y. (2006). CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br. J. Cancer 95, 639-641.
74. Hatakeyama, M. (2003). Helicobacter pylori CagA-a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect. 5, 143-150.
75. Hatakeyama, M. (2004). Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4, 688-694.
76. Hatakeyama, M. (2006). Helicobacter pylori CagA-a bacterial intruder conspiring gastric carcinogenesis. Int. J. Cancer 119, 1217-1223.
77. Hatakeyama, M., and Higashi, H. (2005). Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 96, 835-843.
78. Higashi, H., Nakaya, A., Tsutsumi, R., Yokoyama, K., Fujii, Y., Ishikawa, S., Higuchi, M., Takahashi, A., Kurashima, Y., Teishikata, Y., Tanaka, S., Azuma, T., and Hatakeyama, M. (2004). Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279, 17205-17216.
79. Higashi, H., Tsutsumi, R., Fujita, A., Yamazaki, S., Asaka, M., Azuma, T., and Hatakeyama, M. (2002a). Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. U.S.A. 99, 14428-14433.
80. Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M., and Hatakeyama, M. (2002b). SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683-686.
81. Higuchi, M., Tsutsumi, R., Higashi, H., and Hatakeyama, M. (2004). Conditional gene silencing utilizing the lac repressor reveals a role of SHP-2 in cagA-positive Helicobacter pylori pathogenicity. Cancer Sci. 95, 442-447.
82. Hirata, Y., Maeda, S., Mitsuno, Y., Tateishi, K., Yanai, A., Akanuma, M., Yoshida, H., Kawabe, T., Shiratori, Y., and Omata, M. (2002). Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology 123, 1962-1971.
83. Hisatsune, J., Nakayama, M., Isomoto, H., Kurazono, H., Mukaida, N., Mukhopadhyay, A. K., Azuma, T., Yamaoka, Y., Sap, J., Yamasaki, E., Yahiro, K., Moss, J., and Hirayama, T. (2008). Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation. J. Immunol. 180, 5017-5027.
84. Hisatsune, J., Yamasaki, E., Nakayama, M., Shirasaka, D., Kurazono, H., Katagata, Y., Inoue, H., Han, J., Sap, J., Yahiro, K., Moss, J., and Hirayama, T. (2007). Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells. Infect. Immun. 75, 4472-4481.
85. Hotchin, N. A., Cover, T. L., and Akhtar, N. (2000). Cell vacuolation induced by the VacA cytotoxin of Helicobacter pylori is regulated by the Rac1 GTPase. J. Biol. Chem. 275, 14009-14012.
86. Huang, J. Q., Zheng, G. F., Sumanac, K., Irvine, E. J., and Hunt, R. H. (2003). Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125, 1636-1644.
87. Hussein, N. R. (2010). The association of dupA and Helicobacter pylori-related gastroduodenal diseases. Eur. J. Clin. Microbiol. Infect. Dis. 29, 817-821.
88. Ilver, D., Barone, S., Mercati, D., Lupetti, P., and Telford, J. L. (2004). Helicobacter pylori toxin VacA is transferred to host cells via a novel contactdependent mechanism. Cell. Microbiol. 6, 167-174.
89. Infection with Helicobacter pylori. (1994). IARC Monogr. Eval. Carcinog. Risks Hum. 61, 177-240.
90. Isenberg, J. I., Selling, J. A., Hogan, D. L., and Koss, M. A. (1987). Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer. N. Engl. J. Med. 316, 374-379.
91. Jain, J., Valge-Archer, V. E., and Rao, A. (1992). Analysis of the AP-1 sites in the IL-2 promoter. J. Immunol. 148, 1240-1250.
92. Jang, S., Jones, K. R., Olsen, C. H., Joo, Y. M., Yoo, Y. J., Chung, I. S., Cha, J. H., and Merrell, D. S. (2010). Epidemiological link between gastric disease and polymorphisms in VacA and CagA. J. Clin. Microbiol. 48, 559-567.
93. Ji, X., Fernandez, T., Burroni, D., Pagliaccia, C., Atherton, J. C., Reyrat, J. M., Rappuoli, R., and Telford, J. L. (2000). Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion. Infect. Immun. 68, 3754-3757.
94. Jones, K. R., Joo, Y. M., Jang, S., Yoo, Y. J., Lee, H. S., Chung, I. S., Olsen, C. H., Whitmire, J. M., Merrell, D. S., and Cha, J. H. (2009). Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J. Clin. Microbiol. 47, 959-968.
95. Jung, S. W., Sugimoto, M., Graham, D. Y., and Yamaoka, Y. (2009). homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J. Clin. Microbiol. 47, 3241-3245.
96. Kaparakis, M., Turnbull, L., Carneiro, L., Firth, S., Coleman, H. A., Parkington, H. C., Le Bourhis, L., Karrar, A., Viala, J., Mak, J., Hutton, M. L., Davies, J. K., Crack, P. J., Hertzog, P. J., Philpott, D. J., Girardin, S. E., Whitchurch, C. B., and Ferrero, R. L. (2010). Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell. Microbiol. 12, 372-385.
97. Keates, S., Keates, A. C., Warny, M., Peek, R. M. Jr., Murray, P. G., and Kelly, C. P. (1999). Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cagHelicobacter pylori. J. Immunol. 163, 5552-5559.
98. Kim, S., Chamberlain, A. K., and Bowie, J. U. (2004). Membrane channel structure of Helicobacter pylori vacuolating toxin: role of multiple GXXXG motifs in cylindrical channels. Proc. Natl. Acad. Sci. U.S.A. 101, 5988-5991.
99. Kim, S. Y., Lee, Y. C., Kim, H. K., and Blaser, M. J. (2006). Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8. Cell. Microbiol. 8, 97-106.
100. Kimura, M., Goto, S., Wada, A., Yahiro, K., Niidome, T., Hatakeyama, T., Aoyagi, H., Hirayama, T., and Kondo, T. (1999). Vacuolating cytotoxin purified from Helicobacter pylori causes mitochondrial damage in human gastric cells. Microb. Pathog. 26, 45-52.
101. Klampfer, L. (2006). Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets 6, 107-121.
102. Kuipers, E. J., Perez-Perez, G. I., Meuwissen, S. G., and Blaser, M. J. (1995). Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl. Cancer Inst. 87, 1777-1780.
103. Kurashima, Y., Murata-Kamiya, N., Kikuchi, K., Higashi, H., Azuma, T., Kondo, S., and Hatakeyama, M. (2008). Deregulation of beta-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int. J. Cancer 122, 823-831.
104. Lamb, A., and Chen, L. F. (2010). The many roads traveled by Helicobacter pylori to NFKappaB activation. Gut Microbes 1, 109-113.
105. Lamb, A., Yang, X. D., Tsang, Y. H., Li, J. D., Higashi, H., Hatakeyama, M., Peek, R. M., Blanke, S. R., and Chen, L. F. (2009). Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep. 10, 1242-1249.
106. Lanzavecchia, S., Bellon, P. L., Lupetti, P., Dallai, R., Rappuoli, R., and Telford, J. L. (1998). Three-dimensional reconstruction of metal replicas of the Helicobacter pylori vacuolating cytotoxin. J. Struct. Biol. 121, 9-18.
107. Lee, I. O., Kim, J. H., Choi, Y. J., Pillinger, M. H., Kim, S. Y., Blaser, M. J., and Lee, Y. C. (2010). Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/ STAT signal transduction pathways in gastric epithelial cells. J. Biol. Chem. 285, 16042-16050.
108. Letley, D. P., and Atherton, J. C. (2000). Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity. J. Bacteriol. 182, 3278-3280.
109. Letley, D. P., Rhead, J. L., Twells, R. J., Dove, B., and Atherton, J. C. (2003). Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J. Biol. Chem. 278, 26734-26741.
110. Leunk, R. D., Johnson, P. T., David, B. C., Kraft, W. G., and Morgan, D. R. (1988). Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 26, 93-99.
111. Levi, S., Beardshall, K., Haddad, G., Playford, R., Ghosh, P., and Calam, J. (1989). Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1, 1167-1168.
112. Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., Bar-Sagi, D., Margolis, B., and Schlessinger, J. (1993). Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363, 85-88.
113. Lickert, H., Domon, C., Huls, G., Wehrle, C., Duluc, I., Clevers, H., Meyer, B. I., Freund, J. N., and Kemler, R. (2000). Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development 127, 3805-3813.
114. Lin, W. C., Tsai, H. F., Kuo, S. H., Wu, M. S., Lin, C. W., Hsu, P. I., Cheng, A. L., and Hsu, P. N. (2010). Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosaassociated lymphoid tissue lymphoma. Cancer Res. 70, 5740-5748.
115. Lu, H., Hsu, P. I., Graham, D. Y., and Yamaoka, Y. (2005). Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128, 833-848.
116. Lu, H., Murata-Kamiya, N., Saito, Y., and Hatakeyama, M. (2009). Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. J. Biol. Chem. 284, 23024-23036.
117. Lu, H. S., Saito, Y., Umeda, M., Murata-Kamiya, N., Zhang, H. M., Higashi, H., and Hatakeyama, M. (2008). Structural and functional diversity in the PAR1b/MARK2-binding region of Helicobacter pylori CagA. Cancer Sci. 99, 2004-2011.
118. Lupetti, P., Heuser, J. E., Manetti, R., Massari, P., Lanzavecchia, S., Bellon, P. L., Dallai, R., Rappuoli, R., and Telford, J. L. (1996). Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J. Cell Biol. 133, 801-807.
119. Marshall, B. J., and Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315.
120. Mashima, H., Suzuki, J., Hirayama, T., Yoshikumi, Y., Ohno, H., Ohnishi, H., Yasuda, H., Fujita, T., and Omata, M. (2008). Involvement of vesicle-associated membrane protein 7 in human gastric epithelial cell vacuolation induced by Helicobacter pylori-produced VacA. Infect. Immun. 76, 2296-2303.
121. Matysiak-Budnik, T., and Megraud, F. (1997). Epidemiology of Helicobacter pylori infection with special reference to professional risk. J. Physiol. Pharmacol. 48(Suppl. 4), 3-17.
122. McClain, M. S., Cao, P., and Cover, T. L. (2001a). Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization. Infect. Immun. 69, 1181-1184.
123. McClain, M. S., Cao, P., Iwamoto, H., Vinion-Dubiel, A. D., Szabo, G., Shao, Z., and Cover, T. L. (2001b). A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J. Bacteriol. 183, 6499-6508.
124. McClain, M. S., Iwamoto, H., Cao, P., Vinion-Dubiel, A. D., Li, Y., Szabo, G., Shao, Z., and Cover, T. L. (2003). Essential role of a GXXXG motif for membrane channel formation by Helicobacter pylori vacuolating toxin. J. Biol. Chem. 278, 12101-12108.
125. Mimuro, H., Suzuki, T., Nagai, S., Rieder, G., Suzuki, M., Nagai, T., Fujita, Y., Nagamatsu, K., Ishijima, N., Koyasu, S., Haas, R., and Sasakawa, C. (2007). Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2, 250-263.
126. Mimuro, H., Suzuki, T., Tanaka, J., Asahi, M., Haas, R., and Sasakawa, C. (2002). Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell 10, 745-755.
127. Mizoshita, T., Inada, K., Tsukamoto, T., Nozaki, K., Joh, T., Itoh, M., Yamamura, Y., Ushijima, T., Nakamura, S., and Tatematsu, M. (2004). Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J. Cancer Res. Clin. Oncol. 130, 29-36.
128. Mizushima, T., Sugiyama, T., Komatsu, Y., Ishizuka, J., Kato, M., and Asaka, M. (2001). Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J. Clin. Microbiol. 39, 2463-2465.
129. Moese, S., Selbach, M., Brinkmann, V., Karlas, A., Haimovich, B., Backert, S., and Meyer, T. F. (2007). The Helicobacter pylori CagA protein disrupts matrix adhesion of gastric epithelial cells by dephosphorylation of vinculin. Cell. Microbiol. 9, 1148-1161.
130. Moese, S., Selbach, M., Kwok, T., Brinkmann, V., Konig, W., Meyer, T. F., and Backert, S. (2004). Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways. Infect. Immun. 72, 3646-3649.
131. Molinari, M., Galli, C., de Bernard, M., Norais, N., Ruysschaert, J. M., Rappuoli, R., and Montecucco, C. (1998a). The acid activation of Helicobacter pylori toxin VacA: structural and membrane binding studies. Biochem. Biophys. Res. Commun. 248, 334-340.
132. Molinari, M., Salio, M., Galli, C., Norais, N., Rappuoli, R., Lanzavecchia, A., and Montecucco, C. (1998b). Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187, 135-140.
133. Molinari, M., Galli, C., Norais, N., Telford, J. L., Rappuoli, R., Luzio, J. P., and Montecucco, C. (1997). Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J. Biol. Chem. 272, 25339-25344.
134. Montecucco, C., and Rappuoli, R. (2001). Living dangerously: how Helicobacter pylori survives in the human stomach. Nat. Rev. Mol. Cell Biol. 2, 457-466.
135. Moss, S. F., Legon, S., Bishop, A. E., Polak, J. M., and Calam, J. (1992). Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340, 930-932.
136. Murata-Kamiya, N., Kurashima, Y., Teishikata, Y., Yamahashi, Y., Saito, Y., Higashi, H., Aburatani, H., Akiyama, T., Peek, R. M. Jr., Azuma, T., and Hatakeyama, M. (2007). Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26, 4617-4626.
137. Nagy, T. A., Frey, M. R., Yan, F., Israel, D. A., Polk, D. B., and Peek, R. M. Jr. (2009). Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J. Infect. Dis. 199, 641-651.
138. Naito, M., Yamazaki, T., Tsutsumi, R., Higashi, H., Onoe, K., Yamazaki, S., Azuma, T., and Hatakeyama, M. (2006). Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130, 1181-1190.
139. Nakayama, M., Hisatsune, J., Yamasaki, E., Isomoto, H., Kurazono, H., Hatakeyama, M., Azuma, T., Yamaoka, Y., Yahiro, K., Moss, J., and Hirayama, T. (2009). Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J. Biol. Chem. 284, 1612-1619.
140. Nakayama, M., Kimura, M., Wada, A., Yahiro, K., Ogushi, K., Niidome, T., Fujikawa, A., Shirasaka, D., Aoyama, N., Kurazono, H., Noda, M., Moss, J., and Hirayama, T. (2004). Helicobacter pylori VacA activates the p38/activating transcription factor 2-mediated signal pathway in AZ-521 cells. J. Biol. Chem. 279, 7024-7028.
141. Neel, B. G., Gu, H., and Pao, L. (2003). The 'Shp'ing news: SH2 domaincontaining tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284-293.
142. Nesic, D., Miller, M. C., Quinkert, Z. T., Stein, M., Chait, B. T., and Stebbins, C. E. (2010). Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat. Struct. Mol. Biol. 17, 130-132.
143. Neugut, A. I., Hayek, M., and Howe, G. (1996). Epidemiology of gastric cancer. Semin. Oncol. 23, 281-291.
144. Nguyen, L. T., Uchida, T., Murakami, K., Fujioka, T., and Moriyama, M. (2008). Helicobacter pylori virulence and the diversity of gastric cancer in Asia. J. Med. Microbiol. 57, 1445-1453.
145. Nguyen, L. T., Uchida, T., Tsukamoto, Y., Kuroda, A., Okimoto, T., Kodama, M., Murakami, K., Fujioka, T., and Moriyama, M. (2009). Helicobacter pylori dupA gene is not associated with clinical outcomes in the Japanese population. Clin. Microbiol. Infect. 16,1264-1269.
146. Nguyen, V. Q., Caprioli, R. M., and Cover, T. L. (2001). Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin. Infect. Immun. 69, 543-546.
147. Odenbreit, S., Swoboda, K., Barwig, I., Ruhl, S., Boren, T., Koletzko, S., and Haas, R. (2009). Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Infect. Immun. 77, 3782-3790.
148. Ogura, K., Maeda, S., Nakao, M., Watanabe, T., Tada, M., Kyutoku, T., Yoshida, H., Shiratori, Y., and Omata, M. (2000). Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med. 192, 1601-1610.
149. Oh, J. D., Karam, S. M., and Gordon, J. I. (2005). Intracellular Helicobacter pylori in gastric epithelial progenitors. Proc. Natl. Acad. Sci. U.S.A. 102, 5186-5191.
150. Ohmae, T., Hirata, Y., Maeda, S., Shibata, W., Yanai, A., Ogura, K., Yoshida, H., Kawabe, T., and Omata, M. (2005). Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes. J. Immunol. 175, 7162-7169.
151. Oldani, A., Cormont, M., Hofman, V., Chiozzi, V., Oregioni, O., Canonici, A., Sciullo, A., Sommi, P., Fabbri, A., Ricci, V., and Boquet, P. (2009). Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog. 5, e1000603. doi: 10.1371/journal. ppat.1000603.
152. Oleastro, M., Cordeiro, R., Yamaoka, Y., Queiroz, D., Megraud, F., Monteiro, L., and Menard, A. (2009). Disease association with two Helicobacter pylori duplicate outer membrane protein genes, homB and homA. Gut Pathog 1, 12.
153. Oliveira, M. J., Costa, A. M., Costa, A. C., Ferreira, R. M., Sampaio, P., Machado, J. C., Seruca, R., Mareel, M., and Figueiredo, C. (2009). CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype. J. Infect. Dis. 200, 745-755.
154. Ono, K., and Han, J. (2000). The p38 signal transduction pathway: activation and function. Cell. Signal. 12, 1-13.
155. Padilla, P. I., Wada, A., Yahiro, K., Kimura, M., Niidome, T., Aoyagi, H., Kumatori, A., Anami, M., Hayashi, T., Fujisawa, J., Saito, H., Moss, J., and Hirayama, T. (2000). Morphologic differentiation of HL-60 cells is associated with appearance of RPTPbeta and induction of Helicobacter pylori VacA sensitivity. J. Biol. Chem. 275, 15200-15206.
156. Pagliaccia, C., de Bernard, M., Lupetti, P., Ji, X., Burroni, D., Cover, T. L., Papini, E., Rappuoli, R., Telford, J. L., and Reyrat, J. M. (1998). The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl. Acad. Sci. U.S.A. 95, 10212-10217.
157. Papini, E., Satin, B., Norais, N., de Bernard, M., Telford, J. L., Rappuoli, R., and Montecucco, C. (1998). Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest. 102, 813-820.
158. Park, B. G., Yoo, C. I., Kim, H. T., Kwon, C. H., and Kim, Y. K. (2005). Role of mitogen-activated protein kinases in hydrogen peroxide-induced cell death in osteoblastic cells. Toxicology 215, 115-125.
159. Park, K. S., Jeon, S. H., Oh, J. W., and Choi, K. Y. (2004). p21Cip/WAF1 activation is an important factor for the ERK pathway dependent anti-proliferation of colorectal cancer cells. Exp. Mol. Med. 36, 557-562.
160. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108.
161. Parsonnet, J., Friedman, G. D., Orentreich, N., and Vogelman, H. (1997). Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40, 297-301.
162. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., and Sibley, R. K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325, 1127-1131.
163. Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich, N., Vogelman, J. H., and Friedman, G. D. (1994). Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330, 1267-1271.
164. Peek, R. M. Jr., Blaser, M. J., Mays, D. J., Forsyth, M. H., Cover, T. L., Song, S. Y., Krishna, U., and Pietenpol, J. A. (1999). Helicobacter pylori strainspecific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res. 59, 6124-6131.
165. Peek, R. M. Jr., Moss, S. F., Tham, K. T., Perez-Perez, G. I., Wang, S., Miller, G. G., Atherton, J. C., Holt, P. R., and Blaser, M. J. (1997). Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl. Cancer Inst. 89, 863-868.
166. Peek, R. M. Jr., Wirth, H. P., Moss, S. F., Yang, M., Abdalla, A. M., Tham, K. T., Zhang, T., Tang, L. H., Modlin, I. M., and Blaser, M. J. (2000). Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 118, 48-59.
167. Poppe, M., Feller, S. M., Romer, G., and Wessler, S. (2007). Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 26, 3462-3472.
168. Pugsley, A. P. (1993). The complete general secretory pathway in Gram-negative bacteria. Microbiol. Rev. 57, 50-108.
169. Rao, A. (1994). NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15, 274-281.
170. Ren, S., Higashi, H., Lu, H., Azuma, T., and Hatakeyama, M. (2006). Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J. Biol. Chem. 281, 32344-32352.
171. Reyrat, J. M., Lanzavecchia, S., Lupetti, P., de Bernard, M., Pagliaccia, C., Pelicic, V., Charrel, M., Ulivieri, C., Norais, N., Ji, X., Cabiaux, V., Papini, E., Rappuoli, R., and Telford, J. L. (1999). 3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin. J. Mol. Biol. 290, 459-470.
172. Rhead, J. L., Letley, D. P., Mohammadi, M., Hussein, N., Mohagheghi, M. A., Eshagh Hosseini, M., and Atherton, J. C. (2007). A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133, 926-936.
173. Rieder, G., Fischer, W., and Haas, R. (2005a). Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr. Opin. Microbiol. 8, 67-73.
174. Rieder, G., Merchant, J. L., and Haas, R. (2005b). Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 128, 1229-1242.
175. Rittig, M. G., Shaw, B., Letley, D. P., Thomas, R. J., Argent, R. H., and Atherton, J. C. (2003). Helicobacter pylori-induced homotypic phagosome fusion in human monocytes is independent of the bacterial vacA and cag status. Cell. Microbiol. 5, 887-899.
176. Roovers, K., and Assoian, R. K. (2000). Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22, 818-826.
177. Saadat, I., Higashi, H., Obuse, C., Umeda, M., Murata-Kamiya, N., Saito, Y., Lu, H., Ohnishi, N., Azuma, T., Suzuki, A., Ohno, S., and Hatakeyama, M. (2007). Helicobacter pylori CagA targets PAR1/ MARK kinase to disrupt epithelial cell polarity. Nature 447, 330-333.
178. Satomi, S., Yamakawa, A., Matsunaga, S., Masaki, R., Inagaki, T., Okuda, T., Suto, H., Ito, Y., Yamazaki, Y., Kuriyama, M., Keida, Y., Kutsumi, H., and Azuma, T. (2006). Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J. Gastroenterol. 41, 668-673.
179. Schmidt, H. M., Andres, S., Kaakoush, N. O., Engstrand, L., Eriksson, L., Goh, K. L., Fock, K. M., Hilmi, I., Dhamodaran, S., Forman, D., and Mitchell, H. (2009). The prevalence of the duodenal ulcer promoting gene (dupA) in Helicobacter pylori isolates varies by ethnic group and is not universally associated with disease development: a case-control study. Gut Pathog 1, 5.
180. Schweitzer, K., Sokolova, O., Bozko, P. M., and Naumann, M. (2010). Helicobacter pylori induces NF-kappaB independent of CagA. EMBO Rep. 11, 10-11; author reply 11-12.
181. Segal, E. D., Cha, J., Lo, J., Falkow, S., and Tompkins, L. S. (1999). Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 96, 14559-14564.
182. Selbach, M., and Backert, S. (2005). Cortactin: an Achilles' heel of the actin cytoskeleton targeted by pathogens. Trends Microbiol. 13, 181-189.
183. Selbach, M., Moese, S., Backert, S., Jungblut, P. R., and Meyer, T. F. (2004). The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics 4, 2961-2968.
184. Selbach, M., Moese, S., Hauck, C. R., Meyer, T. F., and Backert, S. (2002). Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277, 6775-6778.
185. Selbach, M., Moese, S., Hurwitz, R., Hauck, C. R., Meyer, T. F., and Backert, S. (2003). The Helicobacter pylori CagA protein induces cortactin dephos-phorylation and actin rearrangement by c-Src inactivation. EMBO J. 22, 515-528.
186. Selbach, M., Paul, F. E., Brandt, S., Guye, P., Daumke, O., Backert, S., Dehio, C., and Mann, M. (2009). Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe 5, 397-403.
187. Semino-Mora, C., Doi, S. Q., Marty, A., Simko, V., Carlstedt, I., and Dubois, A. (2003). Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J. Infect. Dis. 187, 1165-1177.
188. Sewald, X., Fischer, W., and Haas, R. (2008a). Sticky socks: Helicobacter pylori VacA takes shape. Trends Microbiol. 16, 89-92.
189. Sewald, X., Gebert-Vogl, B., Prassl, S., Barwig, I., Weiss, E., Fabbri, M., Osicka, R., Schiemann, M., Busch, D. H., Semmrich, M., Holzmann, B., Sebo, P., and Haas, R. (2008b). Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe 3, 20-29.
190. Sharma, S. A., Tummuru, M. K., Blaser, M. J., and Kerr, L. D. (1998). Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J. Immunol. 160, 2401-2407.
191. Shibata, W., Hirata, Y., Maeda, S., Ogura, K., Ohmae, T., Yanai, A., Mitsuno, Y., Yamaji, Y., Okamoto, M., Yoshida, H., Kawabe, T., and Omata, M. (2006). CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model. J. Pathol. 210, 306-314.
192. Sokolova, O., Bozko, P. M., and Naumann, M. (2008). Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity. J. Biol. Chem. 283, 29367-29374.
193. Stein, M., Bagnoli, F., Halenbeck, R., Rappuoli, R., Fantl, W. J., and Covacci, A. (2002). c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43, 971-980.
194. Stein, M., Rappuoli, R., and Covacci, A. (2000). Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. U.S.A. 97, 1263-1268.
195. Sun, L., Deng, L., Ea, C. K., Xia, Z. P., and Chen, Z. J. (2004). The TRAF6 ubiq-uitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301.
196. Sundrud, M. S., Torres, V. J., Unutmaz, D., and Cover, T. L. (2004). Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. U.S.A. 101, 7727-7732.
197. Supajatura, V., Ushio, H., Wada, A., Yahiro, K., Okumura, K., Ogawa, H., Hirayama, T., and Ra, C. (2002). Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J. Immunol. 168, 2603-2607.
198. Suzuki, J., Ohnishi, H., Wada, A., Hirayama, T., Ohno, H., Ueda, N., Yasuda, H., Iiri, T., Wada, Y., Futai, M., and Mashima, H. (2003). Involvement of syntaxin 7 in human gastric epithelial cell vacuolation induced by the Helicobacter pylori-produced cytotoxin VacA. J. Biol. Chem. 278, 25585-25590.
199. Suzuki, J., Ohnsihi, H., Shibata, H., Wada, A., Hirayama, T., Iiri, T., Ueda, N., Kanamaru, C., Tsuchida, T., Mashima, H., Yasuda, H., and Fujita, T. (2001). Dynamin is involved in human epithelial cell vacuolation caused by the Helicobacter pylori-produced cytotoxin VacA. J. Clin. Invest. 107, 363-370.
200. Suzuki, M., Mimuro, H., Kiga, K., Fukumatsu, M., Ishijima, N., Morikawa, H., Nagai, S., Koyasu, S., Gilman, R. H., Kersulyte, D., Berg, D. E., and Sasakawa, C. (2009). Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 5, 23-34.
201. Suzuki, M., Mimuro, H., Suzuki, T., Park, M., Yamamoto, T., and Sasakawa, C. (2005). Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J. Exp. Med. 202, 1235-1247.
202. Szabo, I., Brutsche, S., Tombola, F., Moschioni, M., Satin, B., Telford, J. L., Rappuoli, R., Montecucco, C., Papini, E., and Zoratti, M. (1999). Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J. 18, 5517-5527.
203. Tabassam, F. H., Graham, D. Y., and Yamaoka, Y. (2009). Helicobacter pylori activate epidermal growth factor receptorand phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell. Microbiol. 11, 70-82.
204. Takeshima, E., Tomimori, K., Kawakami, H., Ishikawa, C., Sawada, S., Tomita, M., Senba, M., Kinjo, F., Mimuro, H., Sasakawa, C., Fujita, J., and Mori, N. (2009). NF-kappaB activation by Helicobacter pylori requires Aktmediated phosphorylation of p65. BMC Microbiol. 9, 36.
205. Talley, N. J., Zinsmeister, A. R., Weaver, A., DiMagno, E. P., Carpenter, H. A., Perez-Perez, G. I., and Blaser, M. J. (1991). Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst. 83, 1734-1739.
206. Tammer, I., Brandt, S., Hartig, R., Konig, W., and Backert, S. (2007). Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132, 1309-1319.
207. Tartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hahlen, K., Hasle, H., Licht, J. D., and Gelb, B. D. (2003). Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34, 148-150.
208. Tegtmeyer, N., Zabler, D., Schmidt, D., Hartig, R., Brandt, S., and Backert, S. (2009). Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signal- ling for host cell elongation and scat- tering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA. Cell. Microbiol. 11, 488-505.
209. Telford, J. L., Ghiara, P., Dell'Orco, M., Comanducci, M., Burroni, D., Bugnoli, M., Tecce, M. F., Censini, S., Covacci, A., Xiang, Z., Papini, E., Montecucco, C., Parente, L., and Rappuoli, R. (1994). Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179, 1653-1658.
210. Terebiznik, M. R., Raju, D., Vazquez, C. L., Torbricki, K., Kulkarni, R., Blanke, S. R., Yoshimori, T., Colombo, M. I., and Jones, N. L. (2009). Effect of Helicobacter pylori's vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy 5, 370-379.
211. The EUROGAST Study Group. (1993). Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 34, 1672-1676.
212. Tolwinski, N. S., and Wieschaus, E. (2004). Rethinking WNT signaling. Trends Genet. 20, 177-181.
213. Tombola, F., Morbiato, L., Del Giudice, G., Rappuoli, R., Zoratti, M., and Papini, E. (2001). The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J. Clin. Invest. 108, 929-937.
214. Torres, V. J., McClain, M. S., and Cover, T. L. (2004). Interactions between p-33 and p-55 domains of the Helicobacter pylori vacuolating cytotoxin (VacA). J. Biol. Chem. 279, 2324-2331.
215. Torres, V. J., VanCompernolle, S. E., Sundrud, M. S., Unutmaz, D., and Cover, T. L. (2007). Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J. Immunol. 179, 5433-5440.
216. Tsutsumi, R., Higashi, H., Higuchi, M., Okada, M., and Hatakeyama, M. (2003). Attenuation of Helicobacter pylori CagA × SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem. 278, 3664-3670.
217. Tsutsumi, R., Takahashi, A., Azuma, T., Higashi, H., and Hatakeyama, M. (2006). Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol. Cell. Biol. 26, 261-276.
218. Tummuru, M. K., Cover, T. L., and Blaser, M. J. (1993). Cloning and expression of a high-molecular-mass major anti- gen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 61, 1799-1809.
219. Tuo, B., Song, P., Wen, G., Sewald, X., Gebert-Vogl, B., Haas, R., Manns, M., and Seidler, U. (2009). Helicobacter pylori vacuolating cytotoxin inhibits duodenal bicarbonate secretion by a histamine-dependent mechanism in mice. J. Infect. Dis. 199, 505-512.
220. Udhayakumar, G., Jayanthi, V., Devaraj, N., and Devaraj, H. (2007). Interaction of MUC1 with beta-catenin modu- lates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer. Mol. Carcinog. 46, 807-817.
221. Umeda, M., Murata-Kamiya, N., Saito, Y., Ohba, Y., Takahashi, M., and Hatakeyama, M. (2009). Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability. J. Biol. Chem. 284, 22166-22172.
222. Umehara, S., Higashi, H., Ohnishi, N., Asaka, M., and Hatakeyama, M. (2003). Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene 22, 8337-8342.
223. Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Memet, S., Huerre, M. R., Coyle, A. J., DiStefano, P. S., Sansonetti, P. J., Labigne, A., Bertin, J., Philpott, D. J., and Ferrero, R. L. (2004). Nod1 responds to peptidog- lycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5, 1166-1174.
224. Vinion-Dubiel, A. D., McClain, M. S., Czajkowsky, D. M., Iwamoto, H., Ye, D., Cao, P., Schraw, W., Szabo, G., Blanke, S. R., Shao, Z., and Cover, T. L. (1999). A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation. J. Biol. Chem. 274, 37736-37742.
225. Wang, F., Xia, P., Wu, F., Wang, D., Wang, W., Ward, T., Liu, Y., Aikhionbare, F., Guo, Z., Powell, M., Liu, B., Bi, F., Shaw, A., Zhu, Z., Elmoselhi, A., Fan, D., Cover, T. L., Ding, X., and Yao, X. (2008). Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J. Biol. Chem. 283, 26714-26725.
226. Wang, H. J., and Wang, W. C. (2000). Expression and binding analysis of GST-VacA fusions reveals that the C-terminal approximately 100-residue segment of exotoxin is crucial for binding in HeLa cells. Biochem. Biophys. Res. Commun. 278, 449-454.
227. Wang, W. C., Wang, H. J., and Kuo, C. H. (2001). Two distinctive cell binding patterns by vacuolating toxin fused with glutathione S-transferase: one high-affinity m1-specific binding and the other lower-affinity binding for variant m forms. Biochemistry 40, 11887-11896.
228. Watanabe, T., Asano, N., Fichtner-Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y., Chiba, T., Fuss, I. J., Kitani, A., and Strober, W. (2010). NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 120, 1645-1662.
229. Watanabe, T., Tada, M., Nagai, H., Sasaki, S., and Nakao, M. (1998). Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115, 642-648.
230. Weydig, C., Starzinski-Powitz, A., Carra, G., Lower, J., and Wessler, S. (2007). CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity. Exp. Cell Res. 313, 3459-3471.
231. Willhite, D. C., and Blanke, S. R. (2004). Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell. Microbiol. 6, 143-154.
232. Willhite, D. C., Cover, T. L., and Blanke, S. R. (2003). Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation. J. Biol. Chem. 278, 48204-48209.
233. Willhite, D. C., Ye, D., and Blanke, S. R. (2002). Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells. Infect. Immun. 70, 3824-3832.
234. Wirth, H. P., Beins, M. H., Yang, M., Tham, K. T., and Blaser, M. J. (1998). Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infect. Immun. 66, 4856-4866.
235. Xiang, Z., Censini, S., Bayeli, P. F., Telford, J. L., Figura, N., Rappuoli, R., and Covacci, A. (1995). Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63, 94-98.
236. Yahiro, K., Niidome, T., Kimura, M., Hatakeyama, T., Aoyagi, H., Kurazono, H., Imagawa, K., Wada, A., Moss, J., and Hirayama, T. (1999). Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. J. Biol. Chem. 274, 36693-36699.
237. Yahiro, K., Wada, A., Nakayama, M., Kimura, T., Ogushi, K., Niidome, T., Aoyagi, H., Yoshino, K., Yonezawa, K., Moss, J., and Hirayama, T. (2003). Protein-tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J. Biol. Chem. 278, 19183-19189.
238. Yahiro, K., Wada, A., Yamasaki, E., Nakayama, M., Nishi, Y., Hisatsune, J., Morinaga, N., Sap, J., Noda, M., Moss, J., and Hirayama, T. (2004). Essential domain of receptor tyrosine phosphatase beta (RPTPbeta) for interaction with Helicobacter pylori vacuolating cytotoxin. J. Biol. Chem. 279, 51013-51021.
239. Yamamoto, S. (2001). Stomach cancer incidence in the world. Jpn. J. Clin. Oncol. 31, 471.
240. Yamaoka, Y., El-Zimaity, H. M., Gutierrez, O., Figura, N., Kim, J. G., Kodama, T., Kashima, K., and Graham, D. Y. (1999). Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117, 342-349.
241. Yamasaki, E., Wada, A., Kumatori, A., Nakagawa, I., Funao, J., Nakayama, M., Hisatsune, J., Kimura, M., Moss, J., and Hirayama, T. (2006). Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J. Biol. Chem. 281, 11250-11259.
242. Yamazaki, S., Yamakawa, A., Ito, Y., Ohtani, M., Higashi, H., Hatakeyama, M., and Azuma, T. (2003). The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J. Infect. Dis. 187, 334-337.
243. Yang, W. L., Wang, J., Chan, C. H., Lee, S. W., Campos, A. D., Lamothe, B., Hur, L., Grabiner, B. C., Lin, X., Darnay, B. G., and Lin, H. K. (2009). The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134-1138.
244. Ye, D., and Blanke, S. R. (2000). Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation. Infect. Immun. 68, 4354-4357.
245. Ye, D., and Blanke, S. R. (2002). Functional complementation reveals the importance of intermolecular monomer interactions for Helicobacter pylori VacA vacuolating activity. Mol. Microbiol. 43, 1243-1253.
246. Ye, D., Willhite, D. C., and Blanke, S. R. (1999). Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin. J. Biol. Chem. 274, 9277-9282.
247. Yokoyama, K., Higashi, H., Ishikawa, S., Fujii, Y., Kondo, S., Kato, H., Azuma, T., Wada, A., Hirayama, T., Aburatani, H., and Hatakeyama, M. (2005). Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 102, 9661-9666.
248. Yun, M. S., Kim, S. E., Jeon, S. H., Lee, J. S., and Choi, K. Y. (2005). Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J. Cell. Sci. 118, 313-322.
249. Zeaiter, Z., Cohen, D., Musch, A., Bagnoli, F., Covacci, A., and Stein, M. (2008). Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity. Cell. Microbiol. 10, 781-794.
250. Zheng, P. Y., and Jones, N. L. (2003). Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell. Microbiol. 5, 25-40.
251. Zhu, Y., Wang, C., Huang, J., Ge, Z., Dong, Q., Zhong, X., Su, Y., and Zheng, S. (2007). The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis. Cell. Microbiol. 9, 952-961